华健未来-B

开始申购 2026-06-12

未上市

社区社区
资讯资讯
资料资料
公告公告

- 最新
- 推荐
公司概况
公司名称
华健未来－Ｂ
所属市场
SEHK
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
- -
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
华健未来由多位博士共同创立,主要从事针对肿瘤,自身免疫系统疾病和代谢系统疾病创新药物的研发和生产
- 06-12
  股份发售
  全球发售
  全球发售

2026-06-12

招股说明书查看招股说明书

2026-06-12

发行信息

价格范围
81.800HKD
发售规模
73.60M
市值
6.02B
最小购买量
100
杠杆率
待定

2026-06-17

已休市

发行价格
待定

2026-06-22

中签日

抽签率
待定

2026-06-23

上市

热议股票

{"pagemeta":{"title":"华健未来-B(06132)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华健未来-B(06132)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华健未来-B,06132,华健未来-B股票,华健未来-B股票老虎,华健未来-B股票老虎国际,华健未来-B行情,华健未来-B股票行情,华健未来-B股价,华健未来-B股市,华健未来-B股票价格,华健未来-B股票交易,华健未来-B股票购买,华健未来-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华健未来-B(06132)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华健未来-B(06132)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}},"tab":"fillings","symbol":"06132","data":{"stockData":{"symbol":"06132","market":"HK","secType":"STK","nameCN":"华健未来-B","latestPrice":81.8,"timestamp":1781683200000,"preClose":81.8,"halted":9,"volume":0,"delay":0,"changeRate":0,"floatShares":73599600,"shares":73599605,"eps":0,"marketStatus":"待上市","change":0,"latestTime":"06-17 16:00:00","open":81.8,"high":81.8,"low":81.8,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.127,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1782178200000},"marketStatusCode":8,"adr":0,"listingDate":1782144000000,"exchange":"SEHK","adjPreClose":81.8,"openAndCloseTimeList":[[1781659800000,1781668800000],[1781672400000,1781683200000]],"volumeRatio":0,"ipoDetail":{"name":"华健未来－Ｂ","exchange":"SEHK","listingDate":"2026-06-23","sharesOutstanding":73599605,"sharesFloat":73599605,"offerAmount":13600000,"priceRange":"81.800","market":"HK","openProspectusDate":"2026-06-12","openProspectusUrl":"https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0612/2026061200084_c.pdf","purchaseBeginDate":"2026-06-12","purchaseEndDate":"2026-06-17","winningDate":"2026-06-22","currency":"HKD","minPurchaseQuantity":100,"peRate":-40.33,"use":"1、约80.6%或821.3百万港元将用于正在进行及计划中的管线产品临床研究及开发活动提供资金；\n2、约9.4%或95.6百万港元将用于提升研发平台以加强在免疫学、代谢和肿瘤学领域的创新管线，并开拓且开发新临床前药物以加强目前的治疗选项；\n3、约5.0%或50.9百万港元将用于逐步建立商业化团队，并随着候选药物接近商业化而扩大团队，确保产品上市时能有效拓展市场并提供支援；\n4、约5.0%或50.9百万港元将用于一般业务运营及营运资金。","industryId":"204005","industryName":"医疗保健","business":"公司由致力研发自身免疫、代谢及肿瘤学疾病的疗法的行业专家团队创立，透过识别临床需求及从预期结果倒推进行逆向工作，致力提供改良治疗解决方案。","subscribed":1271.26,"marketCap":6020000000,"minimumCapital":8262.49,"overAllotment":true,"lotSize":100,"issueOpenRate":0.1,"subscribeGear":"100,200,300,400,500,600,700,800,900,1000,1500,2000,2500,3000,3500,4000,4500,5000,6000,7000,8000,9000,10000,20000,30000,40000,50000,60000,70000,80000,90000,100000,150000,200000,250000,300000,350000,400000,450000,500000,600000,680000","issueRatio":0.1,"offeringMechanism":"B"},"greyMarketDetail":{"greyDate":"2026-06-22","greyDateTimestamp":1782057600000,"greyOpeningTime":1782116100000,"greyClosingTime":1782124200000,"showGreyQuote":false,"openProspectusDate":"2026-06-12","listingDate":"2026-06-23"},"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"tweetData":null,"newsData":null,"noticeData":{"listData":[{"cdn_pdf":true,"hasAttachments":false,"id":"21385354","market":"hk","labels":[],"media":"港交所","original_id":"N.HK36r21Jopk9","pdf_url":"https://static.tigerbbs.com/7e6ef2d417654179ad88f97a2dde7030","pub_time":1781219700000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"全球发售","symbol":"06132","title":"全球发售","titleType":"股份发售","type":"hkIPO","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2026/0612/2026061200084_c.pdf","us_notice_code":"上市文件 - [发售以供认购]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"上市文件","type_name_en":"Listing Document","titleTypeEn":"Shares Subscription","event_type":"important_notice","event_name":"股份发售","pubTime":"2026-06-12 07:15","pubTimestamp":1781219700,"notice_type":"","filling_tag":"","gpt_icon":0}],"currentPage":1,"bottom":true},"companyData":{"profile":{"compareEarnings":[{"period":"1week","weight":-0.0029},{"period":"1month","weight":-0.0566},{"period":"3month","weight":-0.0588},{"period":"6month","weight":-0.0394},{"period":"1year","weight":0.018},{"period":"ytd","weight":-0.0443}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"华健未来由多位博士共同创立,主要从事针对肿瘤,自身免疫系统疾病和代谢系统疾病创新药物的研发和生产","exchange":"SEHK","name":"华健未来-B","nameEN":"HJ SCIENCE-B"},"aProfile":null}}}